57 related articles for article (PubMed ID: 17599933)
1. Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer.
Buness A; Kuner R; Ruschhaupt M; Poustka A; Sültmann H; Tresch A
Bioinformatics; 2007 Sep; 23(17):2273-80. PubMed ID: 17599933
[TBL] [Abstract][Full Text] [Related]
2. Annotating breast cancer microarray samples using ontologies.
Liu H; Li X; Yoon V; Clarke R
AMIA Annu Symp Proc; 2008 Nov; 2008():414-8. PubMed ID: 18999108
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive genetic analysis of cancer cells.
Popescu NC
J Cell Mol Med; 2000; 4(3):151-163. PubMed ID: 12167284
[TBL] [Abstract][Full Text] [Related]
4. Positive Caricature Transcriptomic Effects Associated with Broad Genomic Aberrations in Colorectal Cancer.
Condorelli DF; Spampinato G; Valenti G; Musso N; Castorina S; Barresi V
Sci Rep; 2018 Oct; 8(1):14826. PubMed ID: 30287863
[TBL] [Abstract][Full Text] [Related]
5. The correlation between gain of chromosome 8q and survival in patients with clear and papillary renal cell carcinoma.
Mehrazin R; Dulaimi E; Uzzo RG; Devarjan K; Pei J; Smaldone MC; Kutikov A; Testa JR; Al-Saleem T
Ther Adv Urol; 2018 Jan; 10(1):3-10. PubMed ID: 29344091
[TBL] [Abstract][Full Text] [Related]
6. Computational prognostic indicators for breast cancer.
Yang X; Ai X; Cunningham JM
Cancer Manag Res; 2014; 6():301-12. PubMed ID: 25050076
[TBL] [Abstract][Full Text] [Related]
7. Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity.
Wolf DM; Lenburg ME; Yau C; Boudreau A; van 't Veer LJ
PLoS One; 2014; 9(2):e88309. PubMed ID: 24516633
[TBL] [Abstract][Full Text] [Related]
8. Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma.
Pradhan MP; Desai A; Palakal MJ
BMC Syst Biol; 2013 Dec; 7():141. PubMed ID: 24369052
[TBL] [Abstract][Full Text] [Related]
9. FRACTALS WITH POINT IMPACT IN FUNCTIONAL LINEAR REGRESSION.
McKeague IW; Sen B
Ann Stat; 2010; 38(4):2559-2586. PubMed ID: 23785219
[TBL] [Abstract][Full Text] [Related]
10. Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis.
Yang X; Vasudevan P; Parekh V; Penev A; Cunningham JM
PLoS One; 2013; 8(2):e56195. PubMed ID: 23441166
[TBL] [Abstract][Full Text] [Related]
11. bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.
Jézéquel P; Frénel JS; Campion L; Guérin-Charbonnel C; Gouraud W; Ricolleau G; Campone M
Database (Oxford); 2013; 2013():bas060. PubMed ID: 23325629
[TBL] [Abstract][Full Text] [Related]
12. Prediction of breast cancer metastasis by gene expression profiles: a comparison of metagenes and single genes.
Burton M; Thomassen M; Tan Q; Kruse TA
Cancer Inform; 2012; 11():193-217. PubMed ID: 23304070
[TBL] [Abstract][Full Text] [Related]
13. Copy number increase of HER-2 in colorectal cancers.
Xiong Y; Fang Z; Zhang C; Qi G; Liu W; Zhang W; Wan J
Oncol Lett; 2011 Mar; 2(2):331-335. PubMed ID: 22866086
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 8q24-Associated Cancers and MYC.
Grisanzio C; Freedman ML
Genes Cancer; 2010 Jun; 1(6):555-9. PubMed ID: 21779458
[TBL] [Abstract][Full Text] [Related]
15. Loss of aquaporin-4 expression and putative function in non-small cell lung cancer.
Warth A; Muley T; Meister M; Herpel E; Pathil A; Hoffmann H; Schnabel PA; Bender C; Buness A; Schirmacher P; Kuner R
BMC Cancer; 2011 May; 11():161. PubMed ID: 21548930
[TBL] [Abstract][Full Text] [Related]
16. C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.
Perez EA; Jenkins RB; Dueck AC; Wiktor AE; Bedroske PP; Anderson SK; Ketterling RP; Sukov WR; Kanehira K; Chen B; Geiger XJ; Andorfer CA; McCullough AE; Davidson NE; Martino S; Sledge GW; Kaufman PA; Kutteh LA; Gralow JR; Harris LN; Ingle JN; Lingle WL; Reinholz MM
J Clin Oncol; 2011 Feb; 29(6):651-9. PubMed ID: 21245420
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T cell acute lymphoblastic leukaemia cell lines by pharmacogenomics.
Youns M; Fu YJ; Zu YG; Kramer A; Konkimalla VB; Radlwimmer B; Sültmann H; Efferth T
Naunyn Schmiedebergs Arch Pharmacol; 2010 Sep; 382(3):221-34. PubMed ID: 20668838
[TBL] [Abstract][Full Text] [Related]
18. Co-expression module analysis reveals biological processes, genomic gain, and regulatory mechanisms associated with breast cancer progression.
Shi Z; Derow CK; Zhang B
BMC Syst Biol; 2010 May; 4():74. PubMed ID: 20507583
[TBL] [Abstract][Full Text] [Related]
19. Classification across gene expression microarray studies.
Buness A; Ruschhaupt M; Kuner R; Tresch A
BMC Bioinformatics; 2009 Dec; 10():453. PubMed ID: 20042109
[TBL] [Abstract][Full Text] [Related]
20. Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
Loussouarn D; Campion L; Leclair F; Campone M; Charbonnel C; Ricolleau G; Gouraud W; Bataille R; Jézéquel P
Br J Cancer; 2009 Jul; 101(1):166-73. PubMed ID: 19513072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
